NCT01364519View on ClinicalTrials.gov

A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Fluticasone Propionate

Dry powder for inhalation, Single Dose, 500mcg

DRUG

Placebo for Fluticasone Propionate

Dry powder for inhalation, Single Dose, placebo

Trial Locations (2)

M23 9QZ

Pfizer Investigational Site, Manchester

SE1 1YR

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01364519 - A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers | Biotech Hunter | Biotech Hunter